Stock Financial Ratios

DYNT / Dynatronics Corp. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)14.24
Enterprise Value ($M)7.48
Book Value ($M)12.32
Book Value / Share3.91
Price / Book1.23
NCAV ($M)18.43
NCAV / Share5.85
Price / NCAV116.21
Income Statement (mra) ($M)
Net Income-1.87
Balance Sheet (mrq) ($M)
Cash & Equivalents5.55
Cash / Share1.76
Quick Ratio0.80
Current Ratio1.76
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.14
Return on Assets (ROA)-0.07
Return on Equity (ROE)-0.15
Identifiers and Descriptors
Central Index Key (CIK)720875
Industry Groups
SIC 3845 - Electromedical and Electrotherapeutic Apparatus
Share Statistics
Common Shares Outstanding (M)4.92
Scoring Models
Piotroski F Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Deferred Income Tax Liabilities Per Share0.00
Intangibles Per Share0.85
Inventory Per Share2.27
Property Plant And Equipment Gross Per Share0.00
Long Term Debt Per Share0.13
Assets Other Current Per Share0.00
Accounts Payable Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Liabilities And Stock Equity Per Share10.07
Current Portion Of Long Term Debt Per Share0.05
Inventory Raw Materials Per Share1.12
Assets Current Per Share6.11
Accumulated Depreciation And Depletion Per Share0.00
Liabilities Current Per Share4.18
Liabilities Per Share6.08
Goodwill Per Share1.36
Minority Interest Per Share0.00
Property Plant And Equipment Net Per Share1.54
Inventory Work In Progress Per Share0.00
Additional Paid In Capital Per Share0.00
Accounts Receivable Per Share1.85
Treasury Stock Per Share0.00
Inventory Finished Goods Per Share1.10
Cash And Equivalents Per Share1.76
Cash Per Share1.76
Assets Other Non Current Per Share0.00
Assets Per Share10.07
Debt Per Share0.05
Retained Earnings Per Share-2.54
Equity Per Share4.00
Property Plant And Equipment Per Share1.54

Related News Stories

Your Daily Pharma Scoop: Lipocine Ahead Of Ad Com, Ohr's MAKO Study Fails, Zafgen Provides Update

2018-01-06 seekingalpha
Today we will discuss Lipocine (LPCN), which fell more than 10% on Friday ahead of the Ad Com for its lead product candidate TLANDO, an oral testosterone replacement therapy (TRT). (243-7)

Your Daily Pharma Scoop: Loxo Data, GW Pharmaceuticals' Q4 Results, Zynerba Positive Data

2017-12-05 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Total Pharma Tracker subscribers get the full version with actionable ideas one day earlier. (500-2)

Dynatronics' (DYNT) CEO Kelvyn Cullimore Jr. on Q1 2018 Results - Earnings Call Transcript

2017-11-14 seekingalpha
Good morning everybody. We welcome you to the Dynatronics Corporation Investor Conference Call to review the results of our quarter ending September 30, 2017, which is the first reporting quarter of the fiscal year 2018. I’m Kelvyn Cullimore Jr., Chief Executive Officer. With me on the line this morning is David Wirthlin, our Chief Financial Officer. (3-0)

BRIEF-Dynatronics to be exclusive U.S. distributor for Zimmer Medizinsysteme's certain therapy equipment

2017-10-23 reuters
* Dynatronics Corp - ‍has signed exclusive distribution agreement for United States with Zimmer Medizinsysteme GMBH for select therapy equipment​ (3-0)

Dynatronics Completes Acquisition of Bird & Cronin, Inc.

2017-10-02 prnewswire
COTTONWOOD HEIGHTS, Utah, Oct. 2, 2017 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: DYNT), today announced that it successfully closed the acquisition of substantially all of the assets of Bird & Cronin, Inc., a manufacturer of orthopedic soft goods and specialty patient care products located in Minneapolis, Minnesota.  The company announced the signing of the purchase agreement on September 27, 2017. (3-0)

CUSIP: 268157401